BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29886325)

  • 1. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
    Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
    Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
    Tonelli M; Naesens L; Gazzarrini S; Santucci M; Cichero E; Tasso B; Moroni A; Costi MP; Loddo R
    Eur J Med Chem; 2017 Jul; 135():467-478. PubMed ID: 28477572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors.
    Göktaş F; Özbil M; Cesur N; Vanderlinden E; Naesens L; Cesur Z
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
    Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes.
    Ma X; Chui WK
    Bioorg Med Chem; 2010 Jan; 18(2):737-43. PubMed ID: 20036565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B; Tonddast-Navaei S; Skolnick J
    Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives.
    Apaydın ÇB; Cesur N; Stevaert A; Naesens L; Cesur Z
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800330. PubMed ID: 31073993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
    Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
    J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
    Zhou X; Lin K; Ma X; Chui WK; Zhou W
    Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones.
    Apaydın ÇB; Tansuyu M; Cesur Z; Naesens L; Göktaş F
    Bioorg Chem; 2021 Jul; 112():104958. PubMed ID: 33979734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).
    Ma X; Xiang G; Yap CW; Chui WK
    Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.
    Yang X; Wedajo W; Yamada Y; Dahlroth SL; Neo JJ; Dick T; Chui WK
    Eur J Med Chem; 2018 Jan; 144():262-276. PubMed ID: 29274493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
    Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
    Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies.
    Bag S; Tawari NR; Sharma R; Goswami K; Reddy MV; Degani MS
    Acta Trop; 2010 Jan; 113(1):48-51. PubMed ID: 19769933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase.
    Bibi M; Qureshi NA; Sadiq A; Farooq U; Hassan A; Shaheen N; Asghar I; Umer D; Ullah A; Khan FA; Salman M; Bibi A; Rashid U
    Eur J Med Chem; 2021 Jan; 210():112986. PubMed ID: 33187806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.
    Bag S; Tawari NR; Queener SF; Degani MS
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):331-9. PubMed ID: 19874136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
    J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates.
    Ma X; Woon RS; Ho PC; Chui WK
    Chem Biol Drug Des; 2009 Sep; 74(3):322-6. PubMed ID: 19703036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.